Capital Dialysis Unit is a clinical research site located in Washington D.C., District of Columbia, United States 20002-2132.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Capital Dialysis Unit has participated in 1 clinical trials.
Therapeutic areas: End-Stage Kidney Disease.
Sponsors: Abbott.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Capital Dialysis Unit has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Capital Dialysis Unit has 1 clinical trials on record. Their work covers End-Stage Kidney Disease.
Capital Dialysis Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.